# Markers of Early Liver Dysfunction Associate With Reduced Heart Rate Variability in Adolescents With Type 1 Diabetes

**Authors:** Vallimayil Velayutham, Paul Z. Benitez-Aguirre, Gerald Liew, Alicia J. Jenkins, Maria E. Craig, Kim C. Donaghue

PMC · DOI: 10.1155/pedi/1910554 · Pediatric Diabetes · 2025-05-15

## TL;DR

Higher liver enzyme levels in teens with type 1 diabetes are linked to early heart nerve dysfunction, suggesting liver issues may worsen diabetes-related complications.

## Contribution

Identifies liver dysfunction markers as predictors of early cardiac autonomic nerve dysfunction in adolescents with type 1 diabetes.

## Key findings

- Elevated ALT and GGT levels independently predict early cardiac autonomic nerve dysfunction.
- Liver enzyme increases are not linked to retinopathy or kidney dysfunction in these patients.

## Abstract

Aim: Data on the impact of metabolic dysfunction-associated fatty liver disease (MAFLD) on diabetes complications in youth with type 1 diabetes are lacking. However, MAFLD is well known to contribute to cardiovascular disease (CVD) in people with type 2 diabetes. We aimed to investigate markers of MAFLD in youth with type 1 diabetes and their relationship with chronic complications.

Methods: A prospective study of 102 adolescents (mean age 14.7 ± 1.9 years) with type 1 diabetes underwent repeated annual diabetes complications assessments, including annual measures of liver enzymes. Early cardiac autonomic nerve dysfunction (CAN) was defined as ≥1 abnormality in seven heart rate variability parameters derived from a 10-min resting electrocardiogram. Multivariate generalized estimating equations explored predictors of CAN and other microvascular complications (retinopathy and early kidney dysfunction).

Results: After a median follow-up of 3.5 years (IQR 2.7–4.6), there were significant increases in the mean alanine transaminase level (ALT) and systolic blood pressure (SBP) percentiles. Upper ALT and gamma-glutamyl transferase (GGT) tertiles (T3 vs. T1-2: odds ratio [OR], 95% confidence interval [CI], 2.05 [1.20, 3.48], and 2.99 [1.61, 5.58], respectively) predicted CAN development (23%, n = 24) independent of HbA1c and diabetes duration. They were not associated with retinopathy or early kidney dysfunction.

Conclusion: Higher ALT and GGT associate with early CAN in adolescents with type 1 diabetes, suggesting hepatic inflammation may compound the impact of the diabetes milieu on systemic endothelial dysfunction.

## Linked entities

- **Diseases:** type 1 diabetes (MONDO:0005147), cardiovascular disease (CVD) (MONDO:0004995)

## Full-text entities

- **Genes:** GGT1 (gamma-glutamyltransferase 1) [NCBI Gene 2678] {aka CD224, D22S672, D22S732, GGT, GGT 1, GGTD}
- **Diseases:** endothelial dysfunction (MESH:D014652), Liver Dysfunction (MESH:D017093), cardiovascular disease (MESH:D002318), diabetes complications (MESH:D048909), Type 1 Diabetes (MESH:D003922), type 2 diabetes (MESH:D003924), CAN (MESH:D007674), hepatic inflammation (MESH:D007249), cardiac autonomic nerve dysfunction (MESH:D006331), diabetes (MESH:D003920), retinopathy (MESH:D058437), metabolic dysfunction-associated fatty liver disease (MESH:D005234)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12097865/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12097865/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12097865/full.md

---
Source: https://tomesphere.com/paper/PMC12097865